ABRA INVEST asesora a HEMOSOLVE en su desarrollo estratégico

,
Integral service around a transaction
BY : Diego Gutiérrez22/03/2013

ABRA INVEST ha colaborado con HEMOSOLVE (explotación de la “microespuma esclerosante” para el tratamiento de las hemorroides)  mediante el diseño de un plan de desarrollo de clínicas propias y acuerdos con otras instituciones de prestigio.

Historia de la microespuma esclerosante

En 1.993 la familia Cabrera inventó la microespuma esclerosante. Desde entonces ha sido utilizada para tratar las varices con eficacia en más de 25.000 pacientes. Además de tratarse en las 5 clínicas propias Cabrera, el tratamiento es utilizado bajo licencia por instituciones de prestigio como la Clínica Universitaria de Navarra y Sanitas hospitales. Después del éxito del tratamiento de la microespuma para las varices, los inventores han desarrollado la microespuma para las hemorroides.

PUNTOS CLAVES:

1. Tamaño de población afectada amplio:

Las hemorroides sintomáticas afectan al menos al 50% de la población en algún momento de sus vidas, con alrededor del 5% de la población sufriéndolas en cualquier momento.
2. Ventajas frente a la cirugía y otros:
  • Tratamiento ambulatorio en consulta: sin necesidad de anestesia ni cirugía.
  • Sin cuidados específicos post tratamiento pudiendo el paciente continuar con su vida normal.
  • HEMOSOLVE puede curar cualquier tipo de hemorroide. La cirugía solo los más agudos.
  • Procedimiento indoloro y fácilmente repetible: Las molestias son similares a una extracción de sangre.

3. Posición competitiva ventajosa:

  • La tecnología está patentada e IIDF posee autorización de uso para España.
  • El tratamiento ha sido probado en más de 150 pacientes durante 2011 y 2012 demostrando su eficacia. La Clínica de Granada está activa.
  • Acuerdos con otras instituciones en marcha: acuerdo con Clínicas Cabrera para que ofrezcan el tratamiento, acuerdo con Médico digestivo para abrir clínica en Madrid, etc.

El equipo compuesto del personal técnico y de profesionales con experiencia empresarial en el mundo sanitario está muy preparado para desarrollar el plan de negocio establecido.

Diego Gutiérrez Zarza

ABRA INVEST
Web: www.abra-invest.com
The M&A Professionals

Meet our services

MEET
OUR
metodologY

Do you want to be up to date?

SUSCRIBE OUR NEWSLETTER

Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
"Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?

M&A NEWS
INDUSTRIAL REPORTS
closearrow-circle-o-downchevron-downcrossmenu